NasdaqCM - Nasdaq Real Time Price USD

SAB Biotherapeutics, Inc. (SABS)

Compare
3.8400
-0.2800
(-6.80%)
At close: January 10 at 4:00:00 PM EST
4.0300
+0.19
+(4.95%)
After hours: January 10 at 6:24:29 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
83,941.2530
50,904.9270
81,140.9310
56,537.9330
Total Liabilities Net Minority Interest
26,641.8120
19,846.7850
42,591.0180
17,530.0980
Total Equity Gross Minority Interest
57,299.4410
31,058.1420
38,549.9130
39,007.8350
Total Capitalization
57,299.4410
31,599.7860
38,549.9130
39,179.8720
Preferred Stock Equity
0.0050
--
--
2.0610
Common Stock Equity
57,299.4360
31,058.1420
38,549.9130
39,007.8350
Capital Lease Obligations
4,856.2100
4,614.4490
6,719.0780
7,415.3130
Net Tangible Assets
57,299.4410
31,058.1420
38,549.9130
39,007.8350
Working Capital
48,093.5460
7,104.1090
23,736.6770
23,393.2840
Invested Capital
58,350.2850
32,372.4510
40,346.6370
39,718.6030
Tangible Book Value
57,299.4360
31,058.1420
38,549.9130
39,007.8350
Total Debt
5,907.0590
5,928.7580
8,515.8020
8,126.0810
Share Issued
9,280.1590
5,094.0910
4,348.7270
4,347.4770
Ordinary Shares Number
9,225.4940
5,039.4260
4,348.7270
4,347.4770
Treasury Shares Number
54.6650
54.6650
--
--
12/31/2020 - 2/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers